홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
Heatmap
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
THW
#5832
abrdn World Healthcare Fund
12.5
5
USD
+0.97%
부문:
금융
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
+0.97%
월간 변동
+3.55%
6달 변화
-3.24%
년간 변동율
+18.51%
이전 종가
12.4
3
Open
12.6
2
Bid
Ask
Low
12.5
5
High
12.6
2
양
20
마켓
주식
금융
THW
Open full chart
Top holdings
Market Value
Shares
Weight %
uniQure NV
43.523 M
745.632 K
8.502%
AZN
AstraZeneca PLC
27.669 M
360.655 K
5.405%
LLY
Eli Lilly & Co
18.423 M
24.146 K
3.599%
SNY
Sanofi SA
17.980 M
380.927 K
3.512%
Roche Holding AG
17.085 M
408.646 K
3.338%
TEVA
Teva Pharmaceutical Industries Ltd
16.417 M
812.718 K
3.207%
Medtronic PLC
15.062 M
158.150 K
2.942%
ISRG
Intuitive Surgical Inc
12.592 M
28.155 K
2.460%
MRK
Merck & Co Inc
12.328 M
146.879 K
2.408%
DHR
Danaher Corp
11.356 M
57.277 K
2.218%
Oxford Biomedica PLC
10.282 M
1.371 M
2.009%
NVO
Novo Nordisk A/S
10.278 M
185.222 K
2.008%
CVS
CVS Health Corp
9.065 M
120.237 K
1.771%
BDX
Becton Dickinson & Co
8.896 M
47.528 K
1.738%
ZTS
Zoetis Inc
8.817 M
60.258 K
1.722%
BSX
Boston Scientific Corp
8.542 M
87.498 K
1.669%
TMO
Thermo Fisher Scientific Inc
8.526 M
17.579 K
1.666%
ARGX
Argenx SE
8.371 M
11.349 K
1.635%
Lonza Group AG
8.019 M
11.993 K
1.567%
Newamsterdam Pharma Co NV
7.822 M
275.023 K
1.528%
뉴스
THW: A Global Healthcare Fund With 11% Yield But Overpays The Distribution (NYSE:THW)
Never Cutters, Part 2: 5 More High Yield CEFs That Have Never Cut The Distribution
7 High-Yield CEFs That Have Never Cut The Distribution In 10 Years Plus
Abrdn World Healthcare Fund Q4 2025 Commentary (THW)
Thames Water seeks extension for super senior funding conditions
Abrdn World Healthcare Fund Q3 2025 Commentary (THW)
Daniel Thwaites reports 5% revenue growth amid cost pressures
HQH: Severely Underperforms Peers (NYSE:HQH)
THQ: Outperforms Peers But Has Limited Growth Potential
THW: Discounted Valuation Due To Higher Interest Rates (NYSE:THW)
CEF Insights: The Future Of Healthcare Investing
Daniel Thwaites reports solid results amid challenging conditions